Securities Exchange Act

$LU faces securities lawsuit alleging false financial statements and weak internal controls from April 2023 through January 2025. Class action deadline set for May 2026.

Federal court certifies class action against Biogen for alleged 2021 securities misrepresentations, affecting purchasers during June-July period.

Alight Inc. ($ALIT) faces class action lawsuit alleging false statements, failed business execution, and unsustainable dividend commitments under Securities Exchange Act.

Eos Energy Enterprises ($EOSE) faces class action lawsuit alleging false statements about production capabilities and battery performance, with downtime exceeding forecasts.

Schall Law Firm seeks investors in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment and integrity.

DJS Law Group files class action against $FBRT for allegedly overstating dividend prospects and misleading shareholders about $0.355 quarterly distributions.

Schall Law Firm seeks investors in $RGNX securities fraud class action over allegedly misleading statements about RGX-111 clinical trial data.

Schall Law Firm seeks $BYND investors for class action alleging false statements about long-lived assets and impairment charges between February-November 2025.

Franklin BSP Realty Trust faces class action lawsuit alleging securities violations over false dividend sustainability statements, requiring shareholders to evaluate exposure.

Schall Law Firm pursuing class action against Franklin BSP Realty Trust for allegedly overstating dividend sustainability. Investors who bought shares between November 2024 and February 2026 may join suit.

Enphase Energy faces securities fraud lawsuit alleging false statements about inventory management and credit exposure preparedness, affecting investors from April-October 2025.

REGENXBIO faces securities fraud lawsuit over alleged misrepresentations about RGX-111's safety and efficacy. A CNS tumor discovery contradicted prior investor statements, causing shareholder losses.

Securities fraud lawsuit filed against uniQure for allegedly making false statements about FDA approval processes and BLA submission timelines, causing investor losses.

Schall Law Firm files securities fraud class action against Picard Medical for allegedly misleading investors through false statements and an alleged "pump and dump" scheme during September-October 2025.

Ardent Health faces securities class action for allegedly inflating receivables through misleading accounting practices. Class period runs July 2024 through November 2025.

REGENXBIO faces securities fraud lawsuit for allegedly making false statements about RGX-111 safety while withholding adverse trial data from investors between February 2022 and January 2026.

Robbins Geller sues Richtech Robotics for misrepresenting Microsoft partnership scope. Stock fell 29% after Microsoft clarified relationship was limited to AI lab, not commercial deal.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements and share price manipulation during fall 2025. Investors who purchased shares during this period may be eligible for damages.

Schall Law Firm launches class action against Beyond Meat for allegedly issuing false statements about asset valuations, affecting shareholders from February-November 2025.

Beyond Meat faces shareholder class action over alleged undisclosed asset impairment charges. Investors who bought stock Feb-Nov 2025 can join litigation by March 24, 2026.